Document 3202 DOCN M94A3202 TI Measuring the impact of HIV/AIDS on Africa's commercial sector. DT 9412 AU Forsythe S; Roberts M; Wongombe J; Gakuru O; AIDSCAP/FHI, Arlington, VA. SO Int Conf AIDS. 1994 Aug 7-12;10(1):13 (abstract no. 026D). Unique Identifier : AIDSLINE ICA10/94369373 AB OBJECTIVE: The objective of this assessment was to determine how the commercial sector in Africa is currently being affected by HIV/AIDS and to project how this impact may change over time. This analysis was performed in order to create greater awareness among business managers and policymakers within the commercial sector regarding the potential financial benefits of HIV/AIDS prevention interventions in the workplace. METHODOLOGY: Interviews were conducted at eight businesses in Kenya to determine the costs of various employee programs and benefits. The focus of the interviews was to identify how revenues and expenditures at the workplace might be affected by HIV/AIDS. RESULTS: A preliminary analysis of a Kenyan transportation business indicated that a 6 percent HIV prevalence in the workplace would result in the loss of profits equal to almost 2 million Shillings per year. In the best case scenario, it was projected that this cost would rise to 3 million shillings per year by the year 2000. This cost equates to a 2 percent decline in profitability for the company in 1994, and a 3 percent decline in profitability by the year 2000. It was projected that the greatest decline in profitability would occur as a result of absenteeism (59%), additional training costs (12%), lost productivity due to funeral attendance (12%), and burial fees (6%). CONCLUSIONS: AIDS is already imposing a substantial burden on African companies whose workers are affected by HIV and AIDS. Declines in revenues and increased expenditures that result from AIDS-related illness within the workforce will further impede the ability of African countries to develop successful industries. If workplace HIV prevention programs can achieve minimal effectiveness in preventing HIV, the cost of such programs are likely to be substantially less than the costs incurred by workplace illness. DE Acquired Immunodeficiency Syndrome/*ECONOMICS/PREVENTION & CONTROL *Commerce Costs and Cost Analysis Employer Health Costs Health Benefit Plans, Employee/*ECONOMICS Health Expenditures Human HIV Infections/*ECONOMICS/PREVENTION & CONTROL Kenya Occupational Health Services MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).